Clinafloxacin CI 960) is superior to standard therapeutics in the treatment of murine listeriosis and Salmonellosis

Zentralblatt fur Bakteriologie

Volumn 286, Issue 3, 1997, Pages 401-412

  Nichterlein, T ^a,b   Bornitz, F ^a   Kretschmar, M ^a   Hof, H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Inst Med Microbiol Hyg Mannheim   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLINAFLOXACIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE;

ANIMAL; ANIMAL SALMONELLOSIS; ARTICLE; CELL CULTURE; DRUG EFFECT; FEMALE; LISTERIOSIS; MICROBIOLOGICAL EXAMINATION; MOUSE; NUDE MOUSE; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM;

AMPICILLIN; ANIMALS; ANTI-INFECTIVE AGENTS; CELLS, CULTURED; CIPROFLOXACIN; FEMALE; FLUOROQUINOLONES; LISTERIA INFECTIONS; MICE; MICE, NUDE; MICROBIAL SENSITIVITY TESTS; PENICILLINS; QUINOLONES; SALMONELLA ENTERICA; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM;

EID: 0030613609     PISSN: 09348840     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0934-8840(97)80099-0     Document Type: Article

References (20)

1. Avril, J. L., I. Couete, M. F. Travert, F. Autuly, and P. Plessis: Sensibilite aux quinolones des Salmonella isolees chez l'homme et l'animal. Pathol. Biol. Paris 43 (1995) 270-273
2. Boisivon, A., N. Dhoyen, and C. Carbon: Activity of CI-960 alone and in combination with amoxicillin against Listeria monocytogenes, and in comparison with other quinolones. J. Antimicrob. Chemother. 36 (1995) 527-530
3. Cohen, M. A., J. W. Gage, M. D. Huband, M. A. Meservey, S. R. Van der Roest, and S. L. Yoder: Efficacy of quinolones in preventing Staphylococcus aureus-induced abscesses in mice. J. Antimicrob. Chemother. 36 (1995) 551-555
4. Dunlap, N. E., N. H. Benjamin, and D. E. Briles: The intracellular nature of salmonella infection during the early stages of mouse typhoid. In: Macrophage-Pathogen-interactions (B. S. Zwilling and T. K. Eisenstein eds.) pp. 303-312, Marcel Dekker, New York (1994)
5. Craig, W. and S. Gudmundsson: Postantibiotic effect. In: Antibiotics in laboratory medicine, 3rd edn. (Lorian, V., ed.), pp. 403-431. Williams and Wilkins Co., Baltimore (1991)
6. Forstall, G. J., C. C. Knapp, and J. A. Washington: Bactericidal activities of DU-6859a and clinafloxacin (CI-960) against staphylococci. Antimicrob. Agents Chemother. 38 (1994) 1868-1870
7. Hof, H.: Therapeutic activities of antibiotics in listeriosis. Infection 19, Suppl. 4 (1991) 229-233
8. Jones, E. M. and A. P. MacGowan: Antimicrobial chemotherapy of human infection due to Listeria monocytogenes. Eur. J. Clin. Microbiol. Inf. Dis. 14 (1995) 165-175
9. Martinez-Martinez, L., I. Suarez, M. C. Ortega, and M. J. Perea: Comparative in vitro activities of new quinolones against coryneform bacteria. Antimicrob. Agents Chemother. 38 (1994) 1439-1441
10. McLaughlin, J., A. Audurier, and A. G. Taylor: Treatment failure of recurrent human listeriosis. J. Antimicrob. Chemother. 27 (1991) 851-857
11. Michelet, C., C. Arvieux, N. Vu, F. Cartier, and J. L. Avril: Comparison of 4 fluoroquinolones against intracellular Listeria monocytogenes. Abstract of the 35th ICAAC E92 (1995) 101
12. Nichterlein, T., M. Kretschmar, C. Budeanu, J. Bauer, W. Linss, and H. Hof: Bay Y 3118, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L 929 cells. Antimicrob. Agents Chemother. 38 (1994) 1501-1506
13. Peterson, L. R. and C. J. Shanholtzer: Tests for bactericidal effects of antimicrobial agents: technical performances and clinical relevance. Clin. Microbiol. Rev. 5 (1992) 420-432
14. Portnoy, D. A.: Innate immunity to a facultative intracellular pathogen. Curr. Opin. Immunol. 4 (1992) 20-24
15. Rubinstein, E. and C. Carbon: The fluoroquinolones-reappraisal. J. Antimicrob. Agents 1 (1992) 147-152
16. Rudin, D. E., P. X. Gao, C. X. Cao, H. C. Neu, and S. C. Silverstein: Gemfibrocil enhances the listeriacidal effects of fluoroquinolone antibiotics in J 774 macrophages. J. Exp. Med. 176 (1992) 1439-1447
17. Skogberg, K., J. Syrjänen, M. Jahkola, O. V. Renkonen, J. Paavonen, J. Ahonen, S. Kontiaien, P. Ruutu, and V. Valtonen: Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin. Infect. Dis. 14 (1992) 815-821
18. Van Ogtrop, M. L., H. Mattie, B. R. Sekh, E. Van Strijen, and R. Van Furth: Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice. Antimicrob. Agents Chemother. 36 (1992) 2375-2380
19. Wexler, H. M., E. Molitoris, D. Reeves, and S. M. Finegold: In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria. J. Antimicrob. Chemother. 34 (1994) 579-584
20. Woods, G. L. and J. A. Washington: Antibacterial susceptibility tests: Dilution and disk diffusion methods. In: Manual of Clinical Microbiology. 6th edn. (Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken eds.) pp. 1327-1341. ASM Press, Washington, DC (1995)